Condition
Acute-On-Chronic Liver Failure clinical trials and research
As of November 12, 2026, Find a Trial lists 17 Acute-On-Chronic Liver Failure clinical trials that are recruiting, at sites in 29 countries (most in China (9), India (3), Germany (3)). By phase: Phase 2 (3), Phase 1 (1), Phase 1/2 (1). The most active sponsors are Third Affiliated Hospital, Sun Yat-Sen University (4), Institute of Liver and Biliary Sciences, India (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 17Clinical trials
- 29Countries
Newest Acute-On-Chronic Liver Failure clinical trials
All recruiting trials (17)
-
Factors that affect how well mesenchymal stromal cell (MSC) therapy works for hepatitis B–related acute-on-chronic liver failure.
This project will look back at people with hepatitis B–related ACLF who received MSC infusions to see which factors affect whether the treatment helps.
-
AS1501 in ACLF: a two-stage dose study in adults with acute-on-chronic liver failure
This Phase II study tests AS1501 given by injection in adults with early ACLF to see if it’s safe and tolerable and to guide dosing.
-
TAK-242 and G-CSF in ACLF: a new treatment approach for adults with acute-on-chronic liver failure
This trial tests whether adding TAK-242, with or without G-CSF, to standard ACLF care helps patients with severe alcoholic hepatitis and ACLF.
-
Using different ROTEM cut-offs to guide blood transfusions before procedures in cirrhosis and ACLF
This will test whether using relaxed ROTEM cut-offs to decide on blood transfusions reduces the number of transfusions without raising bleeding risk for people with cirrhosis or ACLF and severe coagulopathy who need invasive procedures.
-
Ceftazidime-avibactam vs high-dose meropenem for ACLF patients with hospital-acquired infections
This trial tests whether ceftazidime-avibactam can better treat infections in ACLF patients than high-dose meropenem given in extended infusions, aiming to spare carbapenems if possible.
-
Evaluating a new treatment for liver failure and sepsis
This study is testing a new treatment for people with liver failure and sepsis to see if it can help them survive and improve their organ function.
-
Using CytoSorb device for patients with acute on chronic liver failure
This study tests if using the CytoSorb device can help lower bilirubin and ammonia levels and improve muscle strength in patients with severe liver failure.
-
Transplanting stem cells from umbilical cords to treat liver failure
This study is testing if transplanting stem cells from umbilical cords can help people with severe liver failure feel better and improve their health.
-
Micro‑encapsulated hepatocyte transplant into the abdominal cavity for adults with liver failure
This trial will try a single dose of micro‑encapsulated human hepatocytes placed into the abdominal cavity to see if it is safe and helps adults with chronic or acute‑on‑chronic liver failure.
-
F573 injection for treating liver injury and failure
This study is testing if an injection called F573 can help people with liver injury or chronic hepatitis B feel better and recover.
-
Registry for monitoring CytoSorb device use in critically ill patients
This study is collecting information on how the CytoSorb device helps critically ill patients to improve care for conditions like septic shock and acute respiratory distress syndrome.
-
Effects of a new liver support system in patients with acute-on-chronic liver failure
This study tests whether a new liver support system can help patients with acute-on-chronic liver failure recover better and live longer by cleaning their blood.
-
Liver transplantation outcomes for patients with severe liver failure
This study is testing how well liver transplants work for people with severe liver failure compared to those with advanced cirrhosis to see which group has better survival rates and quality of life after the transplant.
-
Combining DPMAS and Low Volume Plasma Exchange for Hepatitis B Related Liver Failure
This study is testing a new treatment combining a special blood filtering system and plasma exchange to see if it helps people with liver failure caused by hepatitis B feel better and improve their health.
-
Predicting liver failure after surgery in patients with chronic liver disease
This study is trying to find out what causes liver failure after surgery in people with chronic liver disease to help doctors better predict risks for their patients.
-
Long-term outcomes for patients recovering from hepatitis B related liver failure
This study looks at the long-term health and recovery of people who have survived liver failure caused by hepatitis B to see how they are doing over time.
-
Treatment of Hepatitis B Related Acute-On-Chronic Liver Failure with Nucleotide/Nucleoside Analogues
This study is testing if three antiviral medications can help people with hepatitis B-related liver failure feel better and improve their chances of recovery.
Related topics
Quick answers
How many Acute-On-Chronic Liver Failure clinical trials are recruiting right now?
17, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 29 countries. The most sites are in China (9 trials), India (3 trials), Germany (3 trials), Belgium (2 trials), Austria (2 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.